Effect of metabolic dysfunction-associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant.
Lok Ka LamJing Tong TanPoh Hwa OoiRuiqi ZhangKwok Hung ChanXianhua MaoIvan F N HungWai Kay SetoMan Fung YuenKa Shing CheungPublished in: Journal of gastroenterology and hepatology (2024)
Metabolic dysfunction-associated steatotic liver disease was a risk factor for poorer immunogenicity to the omicron variant, with a more pronounced waning effect compared among three-dose BNT162b2 recipients.